It should be just a matter of time until IMGN has announcements on partnerships that will cover ROW distribution and sale of MIRV. I can't say if a single company will want everything but the U.S. and China, or if multiple smaller such arrangements will be made, but I don't believe it's IMGN's intent to do it themselves. It's possible that contracting, rather than partnering, will be the answer to certain localities.

With December $6 and $7 calls still in my account I'm certainly hoping we get some news before they expire. I can hardly believe we finally got an approval and we're down, but I still feel certain we'll be in double digits in the not to distant future, most of the Analyst's targets are up around $20, so they're in agreement with me.

Gary